Precocious puberty

E. Kirk Neely, Stephanie Crossen

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Purpose of review: Precocious puberty continues to elicit great interest and concern among medical practitioners, as well as the public. Recent findings: Studies have elucidated neural regulation of puberty by kisspeptin, neurokinin B, and other factors. Cohort studies from the North America and Europe suggest that the age of thelarche may be earlier than determined 2 decades ago, and menarche may be slightly earlier, but the causes are unclear. Long-term outcomes of gonadotropin-releasing hormone analog therapy demonstrate increases in final height in the youngest treated patients, with no apparent adverse bone or reproductive consequences. Summary: Although the appropriate threshold age of onset of central puberty remains uncertain, gonadotropinreleasing hormone analog therapy is well tolerated and effective in suppressing luteinizing hormone pulses and ovarian activity.

Original languageEnglish (US)
Pages (from-to)332-338
Number of pages7
JournalCurrent Opinion in Obstetrics and Gynecology
Volume26
Issue number5
DOIs
StatePublished - Oct 1 2014
Externally publishedYes

Fingerprint

Precocious Puberty
Puberty
Neurokinin B
Kisspeptins
Menarche
Luteinizing Hormone
North America
Age of Onset
Gonadotropin-Releasing Hormone
Cohort Studies
Hormones
Bone and Bones
Therapeutics
3'-(1-butylphosphoryl)adenosine

Keywords

  • Gonadotropin-releasing hormone
  • Histrelin
  • Leuprolide
  • Precocious puberty
  • Thelarche

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Precocious puberty. / Neely, E. Kirk; Crossen, Stephanie.

In: Current Opinion in Obstetrics and Gynecology, Vol. 26, No. 5, 01.10.2014, p. 332-338.

Research output: Contribution to journalReview article

Neely, E. Kirk ; Crossen, Stephanie. / Precocious puberty. In: Current Opinion in Obstetrics and Gynecology. 2014 ; Vol. 26, No. 5. pp. 332-338.
@article{46d7aa807a204fc2a149c57fd7879d52,
title = "Precocious puberty",
abstract = "Purpose of review: Precocious puberty continues to elicit great interest and concern among medical practitioners, as well as the public. Recent findings: Studies have elucidated neural regulation of puberty by kisspeptin, neurokinin B, and other factors. Cohort studies from the North America and Europe suggest that the age of thelarche may be earlier than determined 2 decades ago, and menarche may be slightly earlier, but the causes are unclear. Long-term outcomes of gonadotropin-releasing hormone analog therapy demonstrate increases in final height in the youngest treated patients, with no apparent adverse bone or reproductive consequences. Summary: Although the appropriate threshold age of onset of central puberty remains uncertain, gonadotropinreleasing hormone analog therapy is well tolerated and effective in suppressing luteinizing hormone pulses and ovarian activity.",
keywords = "Gonadotropin-releasing hormone, Histrelin, Leuprolide, Precocious puberty, Thelarche",
author = "Neely, {E. Kirk} and Stephanie Crossen",
year = "2014",
month = "10",
day = "1",
doi = "10.1097/GCO.0000000000000099",
language = "English (US)",
volume = "26",
pages = "332--338",
journal = "Current Opinion in Obstetrics and Gynecology",
issn = "1040-872X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Precocious puberty

AU - Neely, E. Kirk

AU - Crossen, Stephanie

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Purpose of review: Precocious puberty continues to elicit great interest and concern among medical practitioners, as well as the public. Recent findings: Studies have elucidated neural regulation of puberty by kisspeptin, neurokinin B, and other factors. Cohort studies from the North America and Europe suggest that the age of thelarche may be earlier than determined 2 decades ago, and menarche may be slightly earlier, but the causes are unclear. Long-term outcomes of gonadotropin-releasing hormone analog therapy demonstrate increases in final height in the youngest treated patients, with no apparent adverse bone or reproductive consequences. Summary: Although the appropriate threshold age of onset of central puberty remains uncertain, gonadotropinreleasing hormone analog therapy is well tolerated and effective in suppressing luteinizing hormone pulses and ovarian activity.

AB - Purpose of review: Precocious puberty continues to elicit great interest and concern among medical practitioners, as well as the public. Recent findings: Studies have elucidated neural regulation of puberty by kisspeptin, neurokinin B, and other factors. Cohort studies from the North America and Europe suggest that the age of thelarche may be earlier than determined 2 decades ago, and menarche may be slightly earlier, but the causes are unclear. Long-term outcomes of gonadotropin-releasing hormone analog therapy demonstrate increases in final height in the youngest treated patients, with no apparent adverse bone or reproductive consequences. Summary: Although the appropriate threshold age of onset of central puberty remains uncertain, gonadotropinreleasing hormone analog therapy is well tolerated and effective in suppressing luteinizing hormone pulses and ovarian activity.

KW - Gonadotropin-releasing hormone

KW - Histrelin

KW - Leuprolide

KW - Precocious puberty

KW - Thelarche

UR - http://www.scopus.com/inward/record.url?scp=84925792524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925792524&partnerID=8YFLogxK

U2 - 10.1097/GCO.0000000000000099

DO - 10.1097/GCO.0000000000000099

M3 - Review article

VL - 26

SP - 332

EP - 338

JO - Current Opinion in Obstetrics and Gynecology

JF - Current Opinion in Obstetrics and Gynecology

SN - 1040-872X

IS - 5

ER -